Does Zinc help heart health? (Grade B evidence)
Grade B for Zinc on heart health: the balance of RCT evidence favours a benefit, especially in adults with cardiometabolic risk factors, at moderate certainty, at doses varies across trials.
Exact question reviewed
- Population
- adults with cardiometabolic risk factors
- Intervention
- Zinc · varies across trials
- Comparator
- not reported
- Outcome
- heart health
- Time horizon
- not reported
Bottom line. Grade B for Zinc on heart health: the balance of RCT evidence favours a benefit, especially in adults with cardiometabolic risk factors, at moderate certainty, at doses varies across trials. [1 RCT]
- Direction
- benefit
- Magnitude
- GRADE-assessed meta-analysis of 75 studies: zinc supplementation significantly lowered several cardiometabolic risk markers — triglycerides, total cholesterol, fasting blood glucose, HbA1c, insulin resistance (HOMA-IR), and inflammatory markers (CRP, IL-6, TNF-alpha). A broad risk-factor signal across many biomarkers, not a demonstrated reduction in cardiovascular events.
- Grade
- B
- Certainty
- moderate
- Clinical meaning
- small but potentially useful
- Who it applies to
- adults with cardiometabolic risk factors
- Dose / form studied
- varies across trials
- Safety
- not assessed
- The one limitation
- Claim-specific limitation details are not available in this public record.
Reviewed · Evidence last changed · Claim clm_ec_b8-zinc-heart v0
Grade B / moderate: probably helps, and new studies are unlikely to reverse this — but could shrink the effect size.
Who it works for
Best-studied in adults with cardiometabolic risk factors. Recorded studied dose: varies across trials.
Evidence
| Study | Design | Role | Cite |
|---|---|---|---|
| Zinc supplementation and cardiovascular disease risk factors: A GRADE-assessed systematic review and dose-response meta-analysis. | peer-reviewed | supports | PMID:37399684 |
Why this grade
Reasoning trace
The current record stores Grade B at moderate certainty and links 1 publishable source. A claim-specific domain-by-domain grading rationale is not available in this public record, so no reason for upgrading or downgrading is inferred here.
Audit and version
- Claim ID
- ec_b8-zinc-heart
- Claim version
- not reported
- Governance
- legacy, not verified
- Last evidence search
- not reported
- Last editorial review
- 2026-07-16T16:40:43.312Z
Dose & form
Studied intake: varies across trials.
How it stacks up for heart health
- Zinc vs Omega-3 for heart health — Omega-3 Grade B
- Zinc vs CoQ10 for heart health — CoQ10 Grade D
- Zinc vs Berberine for heart health — Berberine Grade B
- Zinc vs Magnesium for heart health — Magnesium Grade B
- Zinc vs Vitamin D for heart health — Vitamin D Grade —
- Zinc vs Vitamin C for heart health — Vitamin C Grade C
- All interventions graded for heart health →
Grade history
No grade changes yet. Initial grade assigned; re-reviewed on every 12 months (Grade A/B) — next review by . Methodology v1.
Re-review cadence: every 12 months (Grade A/B) · next scheduled by · methodology v1.
Frequently asked
How long does Zinc take to work for heart health?
Trials of Zinc for heart health typically report effects within 2–4 weeks, though individual response varies. Studies rarely find benefit inside 1 week for chronic outcomes.
What dose was used in studies of Zinc for heart health?
Studied doses for Zinc in heart health trials cluster around varies across trials. See the dose block for the specific range and how it varies by form.
Does Zinc work for heart health if I'm not deficient?
The effect concentrates in adults with cardiometabolic risk factors. If your baseline is normal, expect a smaller effect than the trial averages.
Zinc or the next-best alternative for heart health?
See the compare block above for the head-to-head with the most-cited alternative. Grade + certainty differences matter more than any single trial.
Related
What this is — and is not
- Evidence description
- GRADE-assessed meta-analysis of 75 studies: zinc supplementation significantly lowered several cardiometabolic risk markers — triglycerides, total cholesterol, fasting blood glucose, HbA1c, insulin resistance (HOMA-IR), and inflammatory markers (CRP, IL-6, TNF-alpha). A broad risk-factor signal across many biomarkers, not a demonstrated reduction in cardiovascular events.
- Substrate's interpretation
- The current reviewed record assigns Grade B at moderate certainty. A domain-by-domain rationale is shown only when recorded.
- Discuss with a clinician
- If you're on medication or have a condition that changes the calculus, bring the interaction & population blocks above to your pharmacist or prescriber before deciding.
- Individualized medical advice
- Not provided here or on any Substrate surface (API, agent tool, embed) — see YMYL policy.
Cite this page
Citation is encouraged. The proposed reuse license is CC-BY-4.0; status: pending-governance-ratification.
Plain-text citation
Substrate. Does Zinc help heart health? (Grade B). https://evidencebased.info/interventions/zinc/heart-health. Updated 2026-07-16.
BibTeX
@misc{substrate_tionszinchearthealth,
author = {Substrate editorial},
title = {Does Zinc help heart health?},
year = {2026},
url = {https://evidencebased.info/interventions/zinc/heart-health},
note = {Grade B, evidencebased.info}
}Found something wrong on this page? Report an error →